Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 277 to 280 of 280 entries
Sorted by: Best Match Show Resources per page
Optimized EGFR Blockade Strategies in .

Clinical cancer research : an official journal of the American Association for Cancer Research

Corso S, Pietrantonio F, Apicella M, Migliore C, Conticelli D, Petrelli A, D'Errico L, Durando S, Moya-Rull D, Bellomo SE, Ughetto S, Degiuli M, Reddavid R, Fumagalli U, De Pascale S, Sgroi G, Rausa E, Baiocchi GL, Molfino S, De Manzoni G, Bencivenga M, Siena S, Sartore-Bianchi A, Morano F, Corallo S, Prisciandaro M, Di Bartolomeo M, Gloghini A, Marsoni S, Sottile A, Sapino A, Marchiò C, Dahle-Smith A, Miedzybrodzka Z, Lee J, Ali SM, Ross JS, Alexander BM, Miller VA, Petty R, Schrock AB, Giordano S.
PMID: 33542076
Clin Cancer Res. 2021 Jun 01;27(11):3126-3140. doi: 10.1158/1078-0432.CCR-20-0121. Epub 2021 Feb 04.

PURPOSE: Gastric and gastroesophageal adenocarcinomas represent the third leading cause of cancer mortality worldwide. Despite significant therapeutic improvement, the outcome of patients with advanced gastroesophageal adenocarcinoma is poor. Randomized clinical trials failed to show a significant survival benefit in...

Cite
Corso S, Pietrantonio F, Apicella M, et al. Optimized EGFR Blockade Strategies in . Clin Cancer Res. 2021;27(11):3126-3140doi: 10.1158/1078-0432.CCR-20-0121.
Corso, S., Pietrantonio, F., Apicella, M., Migliore, C., Conticelli, D., Petrelli, A., D'Errico, L., Durando, S., Moya-Rull, D., Bellomo, S. E., Ughetto, S., Degiuli, M., Reddavid, R., Fumagalli, U., De Pascale, S., Sgroi, G., Rausa, E., Baiocchi, G. L., Molfino, S., De Manzoni, G., Bencivenga, M., Siena, S., Sartore-Bianchi, A., Morano, F., Corallo, S., Prisciandaro, M., Di Bartolomeo, M., Gloghini, A., Marsoni, S., Sottile, A., Sapino, A., Marchiò, C., Dahle-Smith, A., Miedzybrodzka, Z., Lee, J., Ali, S. M., Ross, J. S., Alexander, B. M., Miller, V. A., Petty, R., Schrock, A. B., & Giordano, S. (2021). Optimized EGFR Blockade Strategies in . Clinical cancer research : an official journal of the American Association for Cancer Research, 27(11), 3126-3140. https://doi.org/10.1158/1078-0432.CCR-20-0121
Corso, Simona, et al. "Optimized EGFR Blockade Strategies in ." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,11 (2021): 3126-3140. doi: https://doi.org/10.1158/1078-0432.CCR-20-0121
Corso S, Pietrantonio F, Apicella M, Migliore C, Conticelli D, Petrelli A, D'Errico L, Durando S, Moya-Rull D, Bellomo SE, Ughetto S, Degiuli M, Reddavid R, Fumagalli U, De Pascale S, Sgroi G, Rausa E, Baiocchi GL, Molfino S, De Manzoni G, Bencivenga M, Siena S, Sartore-Bianchi A, Morano F, Corallo S, Prisciandaro M, Di Bartolomeo M, Gloghini A, Marsoni S, Sottile A, Sapino A, Marchiò C, Dahle-Smith A, Miedzybrodzka Z, Lee J, Ali SM, Ross JS, Alexander BM, Miller VA, Petty R, Schrock AB, Giordano S. Optimized EGFR Blockade Strategies in . Clin Cancer Res. 2021 Jun 01;27(11):3126-3140. doi: 10.1158/1078-0432.CCR-20-0121. Epub 2021 Feb 04. PMID: 33542076.
Copy Download .nbib Format: NLM
JPEG Pleno holography: scope and technology validation procedures.

Applied optics

Kizhakkumkara Muhamad R, Birnbaum T, Gilles A, Mahmoudpour S, Oh KJ, Pereira M, Perra C, Pinheiro A, Schelkens P.
PMID: 33690446
Appl Opt. 2021 Jan 20;60(3):641-651. doi: 10.1364/AO.404305.

JPEG Pleno is a standardization framework addressing the compression and signaling of plenoptic modalities. While the standardization of solutions to handle light field content is currently reaching its final stage, the Joint Photographic Experts Group (JPEG) committee is now...

Cite
Kizhakkumkara Muhamad R, Birnbaum T, Gilles A, et al. JPEG Pleno holography: scope and technology validation procedures. Appl Opt. 2021;60(3):641-651doi: 10.1364/AO.404305.
Kizhakkumkara Muhamad, R., Birnbaum, T., Gilles, A., Mahmoudpour, S., Oh, K. J., Pereira, M., Perra, C., Pinheiro, A., & Schelkens, P. (2021). JPEG Pleno holography: scope and technology validation procedures. Applied optics, 60(3), 641-651. https://doi.org/10.1364/AO.404305
Kizhakkumkara Muhamad, Raees, et al. "JPEG Pleno holography: scope and technology validation procedures." Applied optics vol. 60,3 (2021): 641-651. doi: https://doi.org/10.1364/AO.404305
Kizhakkumkara Muhamad R, Birnbaum T, Gilles A, Mahmoudpour S, Oh KJ, Pereira M, Perra C, Pinheiro A, Schelkens P. JPEG Pleno holography: scope and technology validation procedures. Appl Opt. 2021 Jan 20;60(3):641-651. doi: 10.1364/AO.404305. PMID: 33690446.
Copy Download .nbib Format: NLM
The impact of cochlear implantation on health-related quality of life in older adults, measured with the Health Utilities Index Mark 2 and Mark 3.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Andries E, Gilles A, Topsakal V, Vanderveken O, Van de Heyning P, Van Rompaey V, Mertens G.
PMID: 33683447
Eur Arch Otorhinolaryngol. 2021 Mar 08; doi: 10.1007/s00405-021-06727-3. Epub 2021 Mar 08.

PURPOSE: To determine the usefulness of the Health Utilities Index (HUI) in older cochlear implant (CI) recipients, the primary aims were: (1) to assess health-related quality of life (HRQoL), measured with HUI, in older CI candidates while comparing with...

Cite
Andries E, Gilles A, Topsakal V, et al. The impact of cochlear implantation on health-related quality of life in older adults, measured with the Health Utilities Index Mark 2 and Mark 3. Eur Arch Otorhinolaryngol. 2021;doi: 10.1007/s00405-021-06727-3.
Andries, E., Gilles, A., Topsakal, V., Vanderveken, O., Van de Heyning, P., Van Rompaey, V., & Mertens, G. (2021). The impact of cochlear implantation on health-related quality of life in older adults, measured with the Health Utilities Index Mark 2 and Mark 3. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, . https://doi.org/10.1007/s00405-021-06727-3
Andries, Ellen, et al. "The impact of cochlear implantation on health-related quality of life in older adults, measured with the Health Utilities Index Mark 2 and Mark 3." European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery vol. (2021). doi: https://doi.org/10.1007/s00405-021-06727-3
Andries E, Gilles A, Topsakal V, Vanderveken O, Van de Heyning P, Van Rompaey V, Mertens G. The impact of cochlear implantation on health-related quality of life in older adults, measured with the Health Utilities Index Mark 2 and Mark 3. Eur Arch Otorhinolaryngol. 2021 Mar 08; doi: 10.1007/s00405-021-06727-3. Epub 2021 Mar 08. PMID: 33683447.
Copy Download .nbib Format: NLM
Pharmacological effects of ex vivo mesenchymal stem cell immunotherapy in patients with acute kidney injury and underlying systemic inflammation.

Stem cells translational medicine

Swaminathan M, Kopyt N, Atta MG, Radhakrishnan J, Umanath K, Nguyen S, O'Rourke B, Allen A, Vaninov N, Tilles A, LaPointe E, Blair A, Gemmiti C, Miller B, Parekkadan B, Barcia RN.
PMID: 34581517
Stem Cells Transl Med. 2021 Dec;10(12):1588-1601. doi: 10.1002/sctm.21-0043. Epub 2021 Sep 28.

Mesenchymal stem cells (MSCs) have natural immunoregulatory functions that have been explored for medicinal use as a cell therapy with limited success. A phase Ib study was conducted to evaluate the safety and immunoregulatory mechanism of action of MSCs...

Cite
Swaminathan M, Kopyt N, Atta MG, et al. Pharmacological effects of ex vivo mesenchymal stem cell immunotherapy in patients with acute kidney injury and underlying systemic inflammation. Stem Cells Transl Med. 2021;10(12):1588-1601doi: 10.1002/sctm.21-0043.
Swaminathan, M., Kopyt, N., Atta, M. G., Radhakrishnan, J., Umanath, K., Nguyen, S., O'Rourke, B., Allen, A., Vaninov, N., Tilles, A., LaPointe, E., Blair, A., Gemmiti, C., Miller, B., Parekkadan, B., & Barcia, R. N. (2021). Pharmacological effects of ex vivo mesenchymal stem cell immunotherapy in patients with acute kidney injury and underlying systemic inflammation. Stem cells translational medicine, 10(12), 1588-1601. https://doi.org/10.1002/sctm.21-0043
Swaminathan, Madhav, et al. "Pharmacological effects of ex vivo mesenchymal stem cell immunotherapy in patients with acute kidney injury and underlying systemic inflammation." Stem cells translational medicine vol. 10,12 (2021): 1588-1601. doi: https://doi.org/10.1002/sctm.21-0043
Swaminathan M, Kopyt N, Atta MG, Radhakrishnan J, Umanath K, Nguyen S, O'Rourke B, Allen A, Vaninov N, Tilles A, LaPointe E, Blair A, Gemmiti C, Miller B, Parekkadan B, Barcia RN. Pharmacological effects of ex vivo mesenchymal stem cell immunotherapy in patients with acute kidney injury and underlying systemic inflammation. Stem Cells Transl Med. 2021 Dec;10(12):1588-1601. doi: 10.1002/sctm.21-0043. Epub 2021 Sep 28. PMID: 34581517; PMCID: PMC8641088.
Copy Download .nbib Format: NLM
Showing 277 to 280 of 280 entries